Neoadjuvant treatment for HER2 positive early breast cancer – differences between trastuzumab monotherapy and dual anti-HER2 blockade in our clinical practice
2021
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI